These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 9786485)

  • 1. Amino acid substitutions at positions 69, 165, 244 and 275 of the PER-1beta-lactamase do not impair enzyme inactivation by clavulanate.
    Bouthors AT; Jarlier V; Sougakoff W
    J Antimicrob Chemother; 1998 Sep; 42(3):399-401. PubMed ID: 9786485
    [No Abstract]   [Full Text] [Related]  

  • 2. X-ray structure of the Asn276Asp variant of the Escherichia coli TEM-1 beta-lactamase: direct observation of electrostatic modulation in resistance to inactivation by clavulanic acid.
    Swarén P; Golemi D; Cabantous S; Bulychev A; Maveyraud L; Mobashery S; Samama JP
    Biochemistry; 1999 Jul; 38(30):9570-6. PubMed ID: 10423234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overcoming resistance to beta-lactamase inhibitors: comparing sulbactam to novel inhibitors against clavulanate resistant SHV enzymes with substitutions at Ambler position 244.
    Thomson JM; Distler AM; Bonomo RA
    Biochemistry; 2007 Oct; 46(40):11361-8. PubMed ID: 17848099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-function studies of arginine at position 276 in CTX-M beta-lactamases.
    Pérez-Llarena FJ; Cartelle M; Mallo S; Beceiro A; Pérez A; Villanueva R; Romero A; Bonnet R; Bou G
    J Antimicrob Chemother; 2008 Apr; 61(4):792-7. PubMed ID: 18281307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aza-boronic acids as non-beta-lactam inhibitors of AmpC-beta-lactamase.
    Buzzoni V; Blazquez J; Ferrari S; Calò S; Venturelli A; Costi MP
    Bioorg Med Chem Lett; 2004 Aug; 14(15):3979-83. PubMed ID: 15225711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative activities of the beta-lactamase inhibitors YTR 830, clavulanic acid and sulbactam combined with ampicillin and piperacillin against beta-lactamase producing anaerobic bacteria.
    Nord CE
    J Chemother; 1989 Jul; 1(4 Suppl):273-5. PubMed ID: 16312398
    [No Abstract]   [Full Text] [Related]  

  • 7. Molecular aspects of beta-lactamase inhibition and inactivation by clavulanic acid: a review.
    Labia R; Barthélemy M; Peduzzi J
    Drugs Exp Clin Res; 1985; 11(11):765-70. PubMed ID: 3915466
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TEM-158 (CMT-9), a new member of the CMT-type extended-spectrum beta-lactamases.
    Robin F; Delmas J; Brebion A; Dubois D; Constantin JM; Bonnet R
    Antimicrob Agents Chemother; 2007 Nov; 51(11):4181-3. PubMed ID: 17709463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Following the reactions of mechanism-based inhibitors with beta-lactamase by Raman crystallography.
    Helfand MS; Totir MA; Carey MP; Hujer AM; Bonomo RA; Carey PR
    Biochemistry; 2003 Nov; 42(46):13386-92. PubMed ID: 14621983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beta-lactamases of Mycobacterium tuberculosis and Mycobacterium kansasii.
    Segura C; Salvadó M
    Microbiologia; 1997 Sep; 13(3):331-6. PubMed ID: 9353752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Bacterial growth delay in E. coli: demonstration and evaluation of the beta-lactamase post-inhibitor effect on 6 strains with different resistance phenotypes].
    Murbach V; Bronner S; Dhoyen N; Sougakoff W; Monteil H; Jehl F
    Pathol Biol (Paris); 2000 Jun; 48(5):478-84. PubMed ID: 10949845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic study of beta-lactams alone and in combination with beta-lactamase inhibitors against Pseudomonas aeruginosa possessing an inducible beta-lactamase.
    Li C; Nicolau DP; Lister PD; Quintiliani R; Nightingale CH
    J Antimicrob Chemother; 2004 Feb; 53(2):297-304. PubMed ID: 14729755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperproduction of inhibitor-susceptible TEM beta-lactamase is responsible for resistance of Serratia marcescens to beta-lactam-beta-lactamase inhibitor combinations.
    Zhao WH; Hu ZQ; Chen G; Ito R; Shimamura T
    Chemotherapy; 2008; 54(1):31-7. PubMed ID: 18063864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of restoration of sensitivities of resistant Staphylococcus aureus isolates by using cefuroxime and clavulanic acid in combination.
    Jalil A; Niazi ID; Khan SU
    J Ayub Med Coll Abbottabad; 2008; 20(2):28-30. PubMed ID: 19385452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cloning and biochemical characterization of FOX-5, an AmpC-type plasmid-encoded beta-lactamase from a New York City Klebsiella pneumoniae clinical isolate.
    Queenan AM; Jenkins S; Bush K
    Antimicrob Agents Chemother; 2001 Nov; 45(11):3189-94. PubMed ID: 11600376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic detection of extended-spectrum and AmpC beta-lactamases by a new spot-inoculation method and modified three-dimensional extract test: comparison with the conventional three-dimensional extract test.
    Shahid M; Malik A; Agrawal M; Singhal S
    J Antimicrob Chemother; 2004 Sep; 54(3):684-7. PubMed ID: 15294886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The AmpC inhibitor, Syn2190, can be used to reveal extended-spectrum beta-lactamases in Escherichia coli.
    Netzel TC; Jindani I; Hanson N; Turner BM; Smith L; Rand KH
    Diagn Microbiol Infect Dis; 2007 Jul; 58(3):345-8. PubMed ID: 17379469
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The vitro efficacy of beta-lactam and beta-lactamase inhibitors against multidrug resistant clinical strains of Mycobacterium tuberculosis.
    Dinçer I; Ergin A; Kocagöz T
    Int J Antimicrob Agents; 2004 Apr; 23(4):408-11. PubMed ID: 15081094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based enhancement of boronic acid-based inhibitors of AmpC beta-lactamase.
    Weston GS; Blázquez J; Baquero F; Shoichet BK
    J Med Chem; 1998 Nov; 41(23):4577-86. PubMed ID: 9804697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Meropenem-clavulanate: a new strategy for the treatment of tuberculosis?
    Holzgrabe U
    ChemMedChem; 2009 Jul; 4(7):1051-3. PubMed ID: 19462395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.